Short answer

Designers and supply chain managers must proactively build flexibility and redundancy into pharmaceutical supply chains by focusing on dynamic pricing, diversified sourcing, advanced ICT integration, robust inventory management, and resilient logistics.

Field
Innovation & Markets
Source
International Journal of Research in Business and Social Science (2147-4478) (2023)
Method
Exploratory research using semi-structured interviews and secondary data analysis.
Evidence
Strong effect

The COVID-19 pandemic significantly disrupted pharmaceutical supply chains, highlighting the critical roles of pricing, strategic sourcing, ICT, product availability, and logistics management in ensuring resilience. This innovation & markets research insight is drawn from a 2023 study published in International Journal of Research in Business and Social Science (2147-4478). Using Exploratory research using semi-structured interviews and secondary data analysis., researchers explored how this design variable affects real-world outcomes. The key design takeaway: Designers and supply chain managers must proactively build flexibility and redundancy into pharmaceutical supply chains by focusing on dynamic pricing, diversified sourcing, advanced ICT integration, robust inventory management, and resilient logistics.

Study
Innovation & MarketsRecentStrong effect

Pandemic-Driven Pharmaceutical Supply Chain Resilience: Key Drivers and Strategies

The COVID-19 pandemic significantly disrupted pharmaceutical supply chains, highlighting the critical roles of pricing, strategic sourcing, ICT, product availability, and logistics management in ensuring resilience.

International Journal of Research in Business and Social Science (2147-4478) · 2023

01

Key Findings

  • 01Pricing of medications significantly impacted supply chain dynamics.
  • 02Strategic sourcing decisions were crucial for maintaining product flow.
  • 03Information and Communication Technology (ICT) played a vital role in managing disruptions.
  • 04Availability of pharmaceutical products was a major concern.
  • 05Logistics management faced considerable challenges.
02

Application

Design takeaway

Designers and supply chain managers must proactively build flexibility and redundancy into pharmaceutical supply chains by focusing on dynamic pricing, diversified sourcing, advanced ICT integration, robust inventory management, and resilient logistics.

How to apply

When designing or evaluating supply chain systems for critical goods, prioritize strategies that enhance adaptability to unpredictable events, such as developing contingency plans for sourcing and logistics, and integrating real-time data analytics.

Project actions

  • 01When researching supply chains, consider how external shocks like pandemics can reveal weaknesses.
  • 02Investigate how different companies adapted their strategies in response to unforeseen events.
03

Method & Evidence

AimWhat are the key drivers of pharmaceutical supply chain resilience during a pandemic, and what strategies can be implemented to address disruptions?
MethodExploratory research using semi-structured interviews and secondary data analysis.
ProcedureConducted interviews with supply chain professionals in the South African pharmaceutical industry and analyzed industry reports and literature to identify overarching themes and challenges.
ContextPharmaceutical industry supply chains during the COVID-19 pandemic in South Africa.

Variables

IV["Pandemic disruption","Pricing strategies","Sourcing strategies","ICT adoption","Inventory management","Logistics management"]
DV["Supply chain resilience","Product availability","Operational efficiency"]
CV["Regulatory environment","Market size","Geographic location"]
04

Strengths & Limitations

Strengths

  • +Timely and relevant research addressing a critical global issue.
  • +Integration of theoretical frameworks with real-world pandemic experiences.

Limitations

The specific context of South Africa's pharmaceutical market might not directly apply to all other countries.

Reliability & validity

The use of semi-structured interviews and secondary data provides a rich qualitative understanding, but the findings' generalizability might be limited by the specific sample and context. Triangulation of data sources enhances validity.

Think critically

How might the strategies identified for pharmaceutical supply chains be adapted for other critical sectors, such as food or energy, during a global crisis?

05

Design Principles

"Supply chain resilience is achieved through adaptive strategies in pricing, sourcing, technology, inventory, and logistics, particularly under conditions of extreme disruption."

Understanding these drivers is essential for designing robust supply chain strategies that can withstand future global health crises. Proactive adaptation in these areas can mitigate shortages, price volatility, and logistical breakdowns, ensuring continued access to essential medicines.

06

What This Means for Your Design

During the COVID-19 pandemic, the way medicines were priced, where they came from, how technology was used, if there were enough medicines, and how they were delivered all became super important for making sure people could get what they needed.

How to use in your project

  • 1.Use this research to justify the importance of supply chain resilience in your design project, especially if it involves physical products or distribution.
07

Add to My Project

08

Quick Cite

Paragraph starter

The COVID-19 pandemic highlighted critical vulnerabilities in pharmaceutical supply chains, emphasizing the importance of strategic drivers such as dynamic pricing, diversified sourcing, effective ICT integration, product availability management, and robust logistics. These factors are essential for building resilience against future disruptions, ensuring consistent access to essential medicines.

09

Source

International Journal of Research in Business and Social Science (2147-4478)

Covid-19 and the South African pharmaceutical supply chain

journal · 2023

View source

Questions About This Research

What does the research say about pandemic-driven pharmaceutical supply chain resilience: key drivers and strategies?
Designers and supply chain managers must proactively build flexibility and redundancy into pharmaceutical supply chains by focusing on dynamic pricing, diversified sourcing, advanced ICT integration, robust inventory management, and resilient logistics. Evidence: International Journal of Research in Business and Social Science (2147-4478) (2023).
Why does "Pandemic-Driven Pharmaceutical Supply Chain Resilience: Key Drivers and Strategies" matter for design?
Understanding these drivers is essential for designing robust supply chain strategies that can withstand future global health crises. Proactive adaptation in these areas can mitigate shortages, price volatility, and logistical breakdowns, ensuring continued access to essential medicines.
How can designers apply this research?
Designers and supply chain managers must proactively build flexibility and redundancy into pharmaceutical supply chains by focusing on dynamic pricing, diversified sourcing, advanced ICT integration, robust inventory management, and resilient logistics.
What were the main findings?
Pricing of medications significantly impacted supply chain dynamics.. Strategic sourcing decisions were crucial for maintaining product flow.. Information and Communication Technology (ICT) played a vital role in managing disruptions.. Availability of pharmaceutical products was a major concern.
What research method was used?
Exploratory research using semi-structured interviews and secondary data analysis..
How strong is the evidence?
Evidence strength is rated Strong effect, based on a 2023 journal from International Journal of Research in Business and Social Science (2147-4478).
What should I do differently in my next project?
When designing or evaluating supply chain systems for critical goods, prioritize strategies that enhance adaptability to unpredictable events, such as developing contingency plans for sourcing and logistics, and integrating real-time data analytics.
What are the limitations?
The study's focus on South Africa may limit the generalizability of findings to other regions with different healthcare systems and market structures.